Clin2
NCT06867393Likely a fitRecruiting

Safety study of HL-003 in healthy volunteers

Healthy Subjects

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
52 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old and in good general health.
  • Your weight is at least 45 kg (for women) or 50 kg (for men), and your BMI is between 19 and 26.
  • Your kidneys function normally, with a creatinine clearance of 90 or higher.
  • You have not taken any prescription or over-the-counter medications, herbs, or supplements for at least 14 days before the trial.
  • You do not smoke heavily (more than 5 cigarettes a day) or drink alcohol excessively, and you are willing to avoid caffeine, grapefruit, and related foods during the study.
  • You agree to use reliable birth control and not plan pregnancy for 3 months after taking the medication.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07469085Recruiting· Phase 1
Safety study of SV003 in healthy volunteers

This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.

Shanghai
NCT06912295Recruiting· Phase 1
Study of HL-1186 in healthy adults

This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.

Wuxi
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07473570Recruiting· Phase 1
Safety study of GS3-007a in healthy adults

This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.

Shanghai, Shanghai Municipality
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.